The premise for the development of the minispindle pump, planned as an
implantable device for assisted circulation, was to transport 4 L of
water/min in mock circulation with a speed of 12-15,000 rpm against an
afterload of 90 mm Bg. After calculations, the resulting first protot
ype had a spindle rotor with 3 threads (outer diameter, 18 mm; inner d
iameter, 6.2 mm; length, 45 mm) in a U-shaped housing, driven by an el
ectric motor with a cooling system. In mock circulation, this pump mov
ed 7.8 L of water/min at 18,000 rpm. To avoid animal experiments, its
influence on the blood was tested in a Maxima oxygenator. The device c
irculated 4.2 L of blood/min with the same speed. Because of its high
traumatic hemolysis rate (>250 mg% of free hemoglobin after 7 h of pum
ping), the rotor was modified, first without effect at 2.5 threads and
then at 4 threads. In addition, in this third prototype, the flow dir
ection was reversed. This prototype was more effective (4.3 L of blood
/min at 12,000 rpm in the oxygenator) and the hemolysis rate, after a
pumping duration of 8 h, could only be reduced to 180 mg% of free hemo
globin. As a result, a fourth prototype was developed (i.e., the U-sha
pe of the housing was abandoned). This device functioned better than t
he third prototype (4.5 L of blood/min at 12,000 rpm in the oxygenator
), but the blood trauma increased (220 mg% of free hemoglobin after 7
h of pumping). To find out if the oxygenator may be responsible for th
e hemolysis problem, the 16th prototype of the large spindle pump was
tested in the oxygenator. The result was expected, the level of free p
lasma hemoglobin was high again (190 mg%). To verify the function of t
he third and the fourth prototype of the mini-spindle pump, 4 animal e
xperiments were performed. Under normal cardiac conditions, the device
s emptied the left ventricle up to 70% with a speed between 10,500 and
11,200 rpm, moving about 6 L of blood/min (afterload between 65 and 9
0 mm Hg). The hemolysis rates were between 32 and 90 mg% of free hemog
lobin in the plasma.